Glenview Capital Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Glenview Capital Management’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,783	Closed	-$3.16M	–	69
2021 Q2	$3.16M	Buy	+15,783	New	+$3.2M	0.05%	63

Other funds holding SNCE

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TLP

Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Glenview Capital Management's SNCE Position: Q3 2021 in Review

Glenview Capital Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2021, closing a stake of 15,783 shares — an estimated $3.16M sold.

Glenview Capital Management first reported a position in SNCE in Q2 2021 and held it in 1 quarter. The position peaked at $3.16M in Q2 2021. 25 funds tracked by Wall St. Rank hold SNCE as of Q3 2021.

Glenview Capital Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Glenview Capital Management sold 15,783 Science 37 Holdings, Inc. Common Stock shares in Q3 2021, an estimated $3.16M.
Glenview Capital Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Glenview Capital Management's Science 37 Holdings, Inc. Common Stock position peaked at $3.16M in Q2 2021.
25 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2021.

Based on Glenview Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.